DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
NCT00225420
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
leuprolide acetate
Normalized identity: leuprolide acetateView linked drug · Find medicine records ·
Find other trials using this name
RADIATION · Unmapped registry intervention
radiation therapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedDocetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
leuprolide acetateDRUG · verified · RxNorm: leuprolide acetate
radiation therapyRADIATION
Sponsors & collaborators
UNC Lineberger Comprehensive Cancer Centerlead sponsor
Sanoficollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00225420 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.